Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
| Website: | www.minervaneurosciences.com |
| Email: | renee@sternir.com |
| Main Phone: | +1 617 600-7373 |
| Address: | 1601 Trapelo Road |
| Address 2: | Suite 284 |
| State: | MA |
| City / Town: | Waltham |
| Country: | USA |
| Postal Code: | 02451 |
| Exchange: | NSD |
| Employees: | 9 |
| NAICS: | Pharmaceutical P |
| Last Price 8.20 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid 6.15 | Bid Size 100.00 | Ask 14.90 | Ask Size 200.00 |
| Open 8.15 | High 8.30 | Low 8.00 | Prev Close 8.20 |
| Last Trade | Volume 158,611 | 52 Wk Hi 14.92 | 52 Wk Low 6.50 |
| Market Cap 348.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 42,454,872.00 | EPS (TTM) -1.00 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 4 | 5 |
| Number of Buys | 2 | 3 |
| Number of Sells | 2 | 2 |
| Net Activity | -1944365 | -1762877 |
| Last 10 Buys | Shares |
|---|---|
| David J. Kupfer | 1,000 |
| David J. Kupfer | 1,000 |
| David J. Kupfer | 1,000 |
| Francesco De Rubertis | 1,000 |
| Michèle Ollier | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Michèle Ollier | 1,000 |
| Francesco De Rubertis | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 17 | 17 | 17 | 17 |
| Low Target Price Estimate | 17 | 17 | 17 | 17 |
| Mean Target Price Estimate | 17 | 17 | 17 | 17 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 08/04/16 | 08/04/16 | 05/27/16 | 08/04/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-12 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 125 | 2016-08-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
